Comparison of Metvix PDT with its vehicle in the treatment of photoaged skin

Journal of Drugs in Dermatology, May, 2007

Sponsored by Galderma. The aim of the study is to assess whether Metvix[R] PDT--a procedure currently marketed in several countries in Europe (including UK and Spain) and in Australia, for the treatment of benign forms of skin cancer (eg, actinic keratosis)--will be effective in correcting the effects related to photodamage and whether it will be well tolerated.

Condition       Intervention           Phase

Photoaged Skin  Procedure: Metvix PDT  Phase II

Study ID Numbers: RD.03.SPR.29057; eudract:2006-004237-15

ClinicalTrials.gov Identifier: NCT00437320

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2007 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale